Vanguard Portfolio Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32B Buy
19,656,540
+436,587
+2% +$29.1M 0.06% 366
2026
Q1
$1.21B Buy
+19,219,953
New +$1.34B 0.06% 361

Other funds holding DXCM

Vanguard Portfolio Management's DXCM Position: Q2 2026 in Review

Vanguard Portfolio Management increased its DexCom (DXCM) stake by 2.3% in Q2 2026, buying an estimated $29.1M and bringing the position to 19,656,540 shares worth $1.32B. The position accounts for 0.06% of the portfolio, ranked #366.

Vanguard Portfolio Management first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 919 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Vanguard Portfolio Management held 19,656,540 shares of DexCom worth $1.32B as of Q2 2026.
  • Vanguard Portfolio Management bought 436,587 DexCom shares in Q2 2026, an estimated $29.1M.
  • DexCom made up 0.06% of Vanguard Portfolio Management's portfolio in Q2 2026, its #366 holding.
  • Vanguard Portfolio Management first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
  • 919 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.